{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:32:36Z","timestamp":1780673556006,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T35OD010991."],"award-info":[{"award-number":["5T35OD010991."]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Canine and human osteosarcomas (OS) are notably similar and have a high rate of metastasis. There is a poor understanding of the tumor development process, predisposing causes, and varying levels of aggression among different cell lines. By characterizing newly developed canine osteosarcoma cell lines, treatments for people and pets can be developed. Of the seven subtypes of OS, three are represented in this group: osteoblastic (the most common), fibroblastic, and giant cell variant. To our knowledge, there are no other giant cell variant canine OS cell lines in the published literature and only one canine fibroblastic osteosarcoma cell line. Understanding the differences between the histologic subtypes in dogs will help to guide comparative research.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Alkaline phosphatase expression was ubiquitous in all cell lines tested and invasiveness was variable between the cell lines tested. Invasiveness and oxidative damage were not correlated with in vivo growth rates, where TOT grew the fastest and had the higher percentage of mice with metastatic lesions. TOL was determined to be the most chemo-resistant during cisplatin chemotherapy while TOM was the most chemo-sensitive.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Further comparisons and studies using these cell lines may identify a variety of characteristics valuable for understanding the disease process and developing treatments for osteosarcoma in both species.<\/jats:p>\n                <jats:p>Some of this data was presented as a poster by KMF at the August 5th, 2017 National Veterinary Scholars Program in Bethesda, MA.<\/jats:p>\n                <jats:p>Characterization of 5 newly generated canine osteosarcoma cell lines.<\/jats:p>\n                <jats:p>Kelli Franks, Tasha Miller, Heather Wilson-Robles.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12917-019-2099-y","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T04:28:23Z","timestamp":1571804903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Characterization of five newly derived canine osteosarcoma cell lines"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6489-8468","authenticated-orcid":false,"given":"Heather","family":"Wilson-Robles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Pool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasha","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"issue":"2","key":"2099_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/bcr577","volume":"5","author":"SE Burdall","year":"2003","unstructured":"Burdall SE, Hanby AM, Lansdown MR, Speirs V. Breast cancer cell lines: friend or foe? Breast Cancer Res. 2003;5(2):89\u201395.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2099_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1677\/erc.1.00795","volume":"12","author":"DM Peehl","year":"2005","unstructured":"Peehl DM. Primary cell cultures as models of prostate cancer development. Endocr Relat Cancer. 2005;12(1):19\u201347.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2099_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12015-017-9720-x","volume":"13","author":"MR Carvalho","year":"2017","unstructured":"Carvalho MR, Lima D, Reis RL, Oliveira JM, Correlo VM. Anti-Cancer drug validation: the contribution of tissue engineered models. Stem Cell Rev. 2017;13(3):347\u201363.","journal-title":"Stem Cell Rev"},{"issue":"4","key":"2099_CR4","first-page":"345","volume":"52","author":"RS Brodey","year":"1979","unstructured":"Brodey RS. The use of naturally occurring cancer in domestic animals for research into human cancer: general considerations and a review of canine skeletal osteosarcoma. Yale J Biol Med. 1979;52(4):345\u201361.","journal-title":"Yale J Biol Med"},{"key":"2099_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/BLO.0b013e318059b8c9","volume":"459","author":"TA Damron","year":"2007","unstructured":"Damron TA, Ward WG, Stewart A. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res. 2007;459:40\u20137.","journal-title":"Clin Orthop Relat Res"},{"key":"2099_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/B978-072160558-6.50026-5","volume-title":"Tumors of the skeletal system","author":"W Dernell","year":"2007","unstructured":"Dernell W, Ehrhart NP, Straw RC, Vail DM. In: Withrow S, editor. Tumors of the skeletal system. St. Louis, MO: Saunders Elsevier; 2007."},{"issue":"3","key":"2099_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0195-5616(85)50061-3","volume":"15","author":"SJ Jongeward","year":"1985","unstructured":"Jongeward SJ. Primary bone tumors. Vet Clin North Am Small Anim Pract. 1985;15(3):609\u201341.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"1","key":"2099_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tvjl.2007.07.025","volume":"175","author":"H Wilson","year":"2008","unstructured":"Wilson H, Huelsmeyer M, Chun R, Young KM, Friedrichs K, Argyle DJ. Isolation and characterisation of cancer stem cells from canine osteosarcoma. Vet J. 2008;175(1):69\u201375.","journal-title":"Vet J"},{"issue":"1","key":"2099_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13028-017-0341-9","volume":"59","author":"S Simpson","year":"2017","unstructured":"Simpson S, Dunning MD, de Brot S, Grau-Roma L, Mongan NP, Rutland CS. Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics. Acta Vet Scand. 2017;59(1):71.","journal-title":"Acta Vet Scand"},{"key":"2099_CR10","unstructured":"Foundation AKCCH. Bone Cancer in Dogs \n                    http:\/\/www.akcchf.org\/canine-health\/your-dogshealth\/bone-cancer-in-dogs.html2016"},{"key":"2099_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fonc.2014.00189","volume":"4","author":"MV Guijarro","year":"2014","unstructured":"Guijarro MV, Ghivizzani SC, Gibbs CP. Animal models in osteosarcoma. Front Oncol. 2014;4:189.","journal-title":"Front Oncol"},{"key":"2099_CR12","doi-asserted-by":"crossref","unstructured":"Fan TM. Murine and canine models of appendicular osteosarcoma. Curr Protoc Pharmacol. 2007; Chapter 14:Unit 14 1.","DOI":"10.1002\/0471141755.ph1401s37"},{"key":"2099_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.7150\/jca.2.262","volume":"2","author":"ME Legare","year":"2011","unstructured":"Legare ME, Bush J, Ashley AK, Kato T, Hanneman WH. Cellular and phenotypic characterization of canine osteosarcoma cell lines. J Cancer. 2011;2:262\u201370.","journal-title":"J Cancer"},{"issue":"1A","key":"2099_CR14","first-page":"155","volume":"27","author":"F Mueller","year":"2007","unstructured":"Mueller F, Fuchs B, Kaser-Hotz B. Comparative biology of human and canine osteosarcoma. Anticancer Res. 2007;27(1A):155\u201364.","journal-title":"Anticancer Res"},{"issue":"1","key":"2099_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083144","volume":"9","author":"LY Pang","year":"2014","unstructured":"Pang LY, Gatenby EL, Kamida A, Whitelaw BA, Hupp TR, Argyle DJ. Global gene expression analysis of canine osteosarcoma stem cells reveals a novel role for COX-2 in tumour initiation. PLoS One. 2014;9(1):e83144.","journal-title":"PLoS One"},{"key":"2099_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/1471-2164-10-625","volume":"10","author":"M Paoloni","year":"2009","unstructured":"Paoloni M, Davis S, Lana S, Withrow S, Sangiorgi L, Picci P, et al. Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression. BMC Genomics. 2009;10:625.","journal-title":"BMC Genomics"},{"issue":"3","key":"2099_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/pbc.23341","volume":"58","author":"KS Rankin","year":"2012","unstructured":"Rankin KS, Starkey M, Lunec J, Gerrand CH, Murphy S, Biswas S. Of dogs and men: comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma. Pediatr Blood Cancer. 2012;58(3):327\u201333.","journal-title":"Pediatr Blood Cancer"},{"key":"2099_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1476-4598-8-72","volume":"8","author":"GT Selvarajah","year":"2009","unstructured":"Selvarajah GT, Kirpensteijn J, van Wolferen ME, Rao NA, Fieten H, Mol JA. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times. Mol Cancer. 2009;8:72.","journal-title":"Mol Cancer"},{"issue":"8","key":"2099_CR19","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/labinvest.2011.72","volume":"91","author":"AB Mohseny","year":"2011","unstructured":"Mohseny AB, Machado I, Cai Y, Schaefer KL, Serra M, Hogendoorn PC, et al. Functional characterization of osteosarcoma cell lines provides representative models to study the human disease. Lab Investig. 2011;91(8):1195\u2013205.","journal-title":"Lab Investig"},{"issue":"3","key":"2099_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.tvjl.2010.08.014","volume":"189","author":"E Morello","year":"2011","unstructured":"Morello E, Martano M, Buracco P. Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma. Vet J. 2011;189(3):268\u201377.","journal-title":"Vet J"},{"key":"2099_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-3-319-04843-7_13","volume":"804","author":"CO Rodriguez Jr","year":"2014","unstructured":"Rodriguez CO Jr. Using canine osteosarcoma as a model to assess efficacy of novel therapies: can old dogs teach us new tricks? Adv Exp Med Biol. 2014;804:237\u201356.","journal-title":"Adv Exp Med Biol"},{"key":"2099_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1477-3163-5-14","volume":"5","author":"G Waris","year":"2006","unstructured":"Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog. 2006;5:14.","journal-title":"J Carcinog"},{"issue":"6","key":"2099_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1292\/jvms.60.757","volume":"60","author":"SH Hong","year":"1998","unstructured":"Hong SH, Kadosawa T, Mochizuki M, Matsunaga S, Nishimura R, Sasaki N. Establishment and characterization of two cell lines derived from canine spontaneous osteosarcoma. J Vet Med Sci. 1998;60(6):757\u201360.","journal-title":"J Vet Med Sci"},{"issue":"2","key":"2099_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0002-9440(10)64857-2","volume":"160","author":"TD Oberley","year":"2002","unstructured":"Oberley TD. Oxidative damage in Cancer. Am J Pathol. 2002;160(2):403\u20138.","journal-title":"Am J Pathol"},{"issue":"9","key":"2099_CR25","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3390\/ijms17091430","volume":"17","author":"Shiro Koizume","year":"2016","unstructured":"Koizume S, Miyagi Y. Lipid Droplets: A key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia. Int J Mol Sci. 2016:17(9).","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"2099_CR26","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3390\/molecules23081941","volume":"23","author":"Toni Petan","year":"2018","unstructured":"Petan T, Jarc E, Jusovic M. Lipid Droplets in Cancer: Gardians of Fat in a Stressful World. Molecules. 2018:23(8).","journal-title":"Molecules"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-2099-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12917-019-2099-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-019-2099-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T23:17:03Z","timestamp":1603235823000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-019-2099-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2099"],"URL":"https:\/\/doi.org\/10.1186\/s12917-019-2099-y","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"4 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Animal Care and Use Committee (IACUC) of Texas A&M University approved the mouse studies (AUP 2017\u20130127) included in this manuscript. Additionally, consent to collect tumor tissue after amputation was given by all pet owners and approved under (AUP 2015\u20130350). Additional review of the consent form for client owned animals was reviewed and approved by the Clinical Research Review Committee (CRRC).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"357"}}